Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests Biotech Investing
RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements Cannabis Investing News
Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study Pharmaceutical Investing
Revive Therapeutics Provides Corporate Update on its COVID-19 and Infectious Diseases Programs Cannabis Investing News
WELL Health Announces Automated Phone, SMS and Web-based COVID-19 Triage Tool for Canadians Medical Device Investing
Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A Cannabis Investing News
Cardiol Therapeutics CEO David Elsley: Shoppers Supply Agreement a Significant Milestone Pharmaceutical Investing
RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution Cannabis Investing News
Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19 Pharmaceutical Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
